Startup investors may not be hitting the pause button entirely on venture capital deployments, but recent market activity indicates a noticeable scaling back on mega-rounds. For the week spanning October 10 through October 16, 2026, venture capital activity saw only two startup financings cross the multiple-hundred-million-dollar threshold. Despite the quieter pace at the very top of the market, capital continued to flow heavily into key sectors, led by artificial intelligence infrastructure, robotics-driven construction technology, advanced biotech therapeutics, and specialized healthcare solutions.
The week’s largest financing by a wide margin went to AI infrastructure provider Modal Labs, which commanded a massive $750 million Series D round. Following behind was construction automation unicorn Icon, which secured $200 million to fuel its ongoing expansion in robotic and 3D-printed home building. Beyond these standout figures, a diverse array of high-growth industries attracted substantial investor interest, highlighting a continued appetite for transformative technologies in biotech, insurance tech, medical artificial intelligence, and semiconductor systems.
Modal Labs Takes the Crown With a $750M Series D
At the top of the weekly leaderboard is Modal Labs, a prominent provider of cloud infrastructure designed specifically for AI inference and other high-intensity computational applications. The New York-headquartered company successfully closed a monumental $750 million Series D funding round led by venture capital firm Accel. The transaction values Modal Labs at an impressive $15.75 billion, cementing its status as a heavyweight in the enterprise artificial intelligence ecosystem.
Modal Labs’ massive raise is underpinned by extraordinary financial momentum. The company reported that it recently surpassed an annual revenue run rate of $1 billion, showcasing the explosive demand for robust, scalable cloud infrastructure as global enterprises rapidly scale their deployment of generative AI and machine learning workloads. Investors are betting heavily that Modal Labs will remain a foundational pillar for organizations needing reliable, high-performance computing resources to run complex AI models in production.
Icon Secures $200M to Scale Construction Automation
Securing the second-largest spot on the weekly roundup is Austin, Texas-based Icon. As a pioneer in construction automation and robotics, Icon is widely recognized for its innovative approach to building homes using advanced 3D-printing technology. The company closed on a $200 million Series D funding round jointly led by institutional investment giants Baillie Gifford and BlackRock.
Icon’s latest capital injection comes at a time of robust operational growth. The company reported that it is currently on a steep trajectory, tracking toward a quadrupling of its revenue through 2026. By automating critical phases of residential construction, Icon aims to address persistent housing shortages and labor constraints, making the building process faster, more efficient, and increasingly scalable across various markets.
Biotech Innovators Make Strong Showing With RNA and Gene Therapies
The healthcare and life sciences sectors captured significant attention during the week, highlighted by notable funding rounds for advanced therapeutic developers in Boston and the San Francisco Bay Area.
Boston-based Soufflé Therapeutics, a specialized developer of next-generation RNA therapies, successfully raised $135 million in a Series B financing round. The round was led by the Juvia Group as part of a broad and diverse syndicate of institutional and specialized healthcare investors, signaling strong confidence in the clinical and commercial potential of RNA-based medicine pipelines.
Meanwhile, Estuary Biotherapeutics launched out of stealth and into the public eye in Menlo Park, California, securing a combined $103 million in financing. The developer of genetic medicines tailored for patients suffering from serious kidney diseases structured the funding to include $93 million in a Series A round led by RA Capital Management, alongside $10 million in previously undisclosed seed capital. This substantial initial war chest will allow Estuary to advance its targeted genetic therapies through crucial pre-clinical and early clinical development phases.
AI Tooling and Healthcare Solutions Drive Mid-Tier Investments
Artificial intelligence applications continue to expand beyond pure infrastructure into specialized operational tools and clinical workflows. Labelbox, an eight-year-old developer of technology designed to help enterprises train and evaluate AI models while deploying adaptive agents that improve through real-world experience, picked up $100 million in Series E funding. Infinitum Partners led the financing for the San Francisco-based company, which plays a critical role in helping businesses refine and manage their proprietary machine-learning pipelines.
In the digital health space, Redwood City, California-based Suki announced a $90 million Series E financing round. Suki specializes in conversational AI tools that listen to clinical interactions and automatically generate structured medical documentation, clinical coding assistance, and other essential healthcare workflows. Backers for the latest round included Healthier Capital and Crosslink Capital, reflecting continued investor enthusiasm for technologies that alleviate administrative burnout among medical professionals.
Family care and support platforms also drew major financial backing. Abby Care, a five-year-old San Francisco-based startup operating a platform that enables family members to become certified, paid caregivers delivering professional-grade care at home, closed on $82 million in Series C funding. The financing was led by Transformation Capital, underscoring the growing market demand for innovative caregiving infrastructure and family-centric healthcare delivery models.
Insurance Tech, Semiconductors, and Cloud Spend Management Round Out the Week
The remainder of the top ten rounds showcased diversification into climate-exposed financial services, specialized hardware, and cloud efficiency platforms.
Stand, a three-year-old San Francisco-based insurance provider focusing on residential properties located in regions facing elevated risks of natural disasters, secured $70 million in a Series C funding round. The financing, led by Saga Ventures Management, valued the emerging insurtech firm at $1 billion, highlighting how insurers are adapting underwriting models to address growing climate-related vulnerabilities.
In the hardware and computing space, Portland, Oregon-based Mueon Corp. completed a $65 million Series A funding round led by Maverick Silicon. Mueon is a semiconductor systems company constructing a modular platform specifically tailored for artificial intelligence and hyperscale computing environments, addressing the surging demand for specialized silicon architectures.
Rounding out the week’s top financings, New York-based North.cloud raised $60 million in a Series B round led by PeakSpan Capital. North.cloud operates an infrastructure spend intelligence and automation platform, helping enterprises monitor, analyze, and optimize their complex cloud and AI computing expenditures as corporate technology budgets face increased scrutiny.
Methodology
The data for this weekly roundup is compiled by tracking the largest announced venture capital financing rounds in the Crunchbase database raised by U.S.-based companies between October 10 and October 16, 2026. While the vast majority of substantial venture rounds are promptly logged, minor time lags may occur for transactions reported toward the tail end of the weekly reporting cycle.
